Table 2 Relationship between DEK protein overexpression and clinicopathological features of gastric cancer
From: High expression of DEK predicts poor prognosis of gastric adenocarcinoma
Clinical features | No. of cases | Strongly positive cases (%) | χ 2 | P value |
|---|---|---|---|---|
Age | Â | Â | 0.915 | 0.340 |
<56 | 96 | 55 (57.3%) | Â | Â |
≥56 | 76 | 49 (64.5%) |  |  |
Gender | Â | Â | 0.011 | 0.918 |
Male | 102 | 62 (60.8%) | Â | Â |
Female | 70 | 42 (60.0%) | Â | Â |
Tumor size | Â | Â | 10.501 | 0.001** |
≥5 cm | 73 | 55 (75.3%) |  |  |
<5Â cm | 99 | 49 (49.5%) | Â | Â |
Serosal invasion | Â | Â | 0.283 | 0.596 |
Yes | 81 | 46 (56.8%) | Â | Â |
No | 91 | 48 (52.7%) | Â | Â |
Lauren types | Â | Â | 5.581 | 0.118 |
Intestinal type | 89 | 47 (52.8%) | Â | Â |
Diffuse type | 72 | 51 (70.8%) | Â | Â |
Mixed type | 11 | 6 (54.5%) | Â | Â |
Differentiation | Â | Â | 19.732 | 0.000** |
Well | 67 | 27 (40.3%) | Â | Â |
Moderately | 82 | 58 (70.7%) | Â | Â |
Poorly | 23 | 19 (82.6%) | Â | Â |
LN Metastasis | Â | Â | 1.417 | 0.235 |
Negative | 89 | 50 (56.2%) | Â | Â |
Positive | 83 | 54 (65.1%) | Â | Â |
Clinical stage | Â | Â | 7.277 | 0.007** |
0-II | 92 | 47 (51.1%) | Â | Â |
III-IV | 80 | 57 (71.3%) | Â | Â |